Fig. 4

Drugs Available for 30-Day Regimens by Drug Class among Selected PHCs (n = 59). The number of 30-day treatment regimens in stock of the day of assessment were tabulated by drug class. Most sites had no 30-day treatment regimens in stock. Of the drugs that were stocked, calcium channel blockers, central acting agents, diuretics and angiotensin converting enzymes inhibitors (ACE-I) were most common